Você procurou por: a study on testing of component based software (Inglês - Birmanês)

Inglês

Tradutor

a study on testing of component based software

Tradutor

Birmanês

Tradutor
Tradutor

Traduza instantaneamente textos, documentos e voz com a Lara

Traduzir agora

Contribuições humanas

A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente

Adicionar uma tradução

Inglês

Birmanês

Informações

Inglês

however, a study on 1,099 cases demonstrates that the incubation period was 3 days on average and ranged from 0 to 24 days.

Birmanês

သို့ရာတွင် လူနာ 1,099 ဦးကို လေ့လာမှုတစ်ခုအရ ပျမ်းမျှရောဂါအစပျိုးချိန်ကာလသည် 3 ရက်ဖြစ်ပြီး အစပျိုးနိုင်သော ကာလမှာ 0 ရက်မှ 24 ရက်အထိ ရှိသည်ကို တွေ့ရသည်။

Última atualização: 2020-08-25
Frequência de uso: 1
Qualidade:

Inglês

"on 2 april 2020, researchers at the university of pittsburgh school of medicine reported on testing of pittcovacc, a possible covid-19 vaccine in mice, stating that ""mna delivered sars-cov-2 s1 subunit vaccines elicited potent antigen-specific antibody responses [in the mice] that were evident beginning 2 weeks after immunization."""

Birmanês

2020 ခုနှစ်၊ ဧပြီလ 2 ရက်နေ့တွင်၊ ပစ္စဘတ်တက္ကသိုလ် ဆေးကျောင်းရှိ စူးစမ်းလေ့လာသူများသည် ဖြစ်နိုင်ချေရှိသော covid-19 ကာကွယ်ဆေးကို ကြွက်များတွင်စမ်းသပ်သော pittcovacc စမ်းသပ်ခြင်းအကြောင်းကို သတင်းပို့ခဲ့ပြီး၊ “mna သည် [ကြွက်များတွင်] ကာကွယ်ဆေးထိုးပြီးနောက် 2 ပတ်တွင်စတင်ကာ သိသာထင်ရှားလာခဲ့သော ဖြစ်နိုင်ချေရှိသည့် ရောဂါဖြစ်စေသည့်ပဋိဇီဝဓာတ်-သီးခြား ကာကွယ်ဆေးကို ထုတ်ယူစေနိုင်သည့် sars-cov-2 s1 ယူနစ်ခွဲကာကွယ်ဆေးကို ဆောင်ကြဉ်းပေးခဲ့ပါသည်။” ဟု ထုတ်ပြန်ထားပါသည်။

Última atualização: 2020-08-25
Frequência de uso: 1
Qualidade:

Aviso: contém formatação HTML invisível

Algumas traduções humanas com pouca relevância foram ocultadas.
Mostrar resultados de pouca relevância.

Consiga uma tradução melhor através
9,218,805,141 de colaborações humanas

Usuários estão solicitando auxílio neste momento:



Utilizamos cookies para aprimorar sua experiência. Se avançar no acesso a este site, você estará concordando com o uso dos nossos cookies. Saiba mais. OK